Cosmo Pharmaceuticals N.V.
SIX:COPN.SW
Overview | Financials
Company Name | Cosmo Pharmaceuticals N.V. |
Symbol | COPN.SW |
Currency | CHF |
Price | 66.8 |
Market Cap | 1,071,863,715 |
Dividend Yield | 1.41% |
52-week-range | 36 - 80.6 |
Industry | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Alessandro E. Della Cha LL.M |
Website | https://www.cosmopharma.com |
An error occurred while fetching data.
About Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, focuses on the development and commercialization products for gastroenterology and endoscopy worldwide. It offers Lialda/Mezavant/Mesavancol and UCERIS/Cortiment, an oral tablet formulation for remission in active, mild to moderate ulcerative colitis; GI Genius, a system that uses artificial intelligence to detect colorectal polyps; and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD